Association between hypertension and immunosuppression in sars-cov-2 infection

Diego Chambergo-Michilot, Isidro Percy Chambergo Campos

Research output: Contribution to journalLetterpeer-review

2 Scopus citations

Abstract

Coronavirus disease 2019 (COVID-19) has caused more than 32 million cases and almost a million deaths. Recent reviews have evidenced the role of hypertension in prognosis, nevertheless, its association with immunosuppression in COVID-19 context has not been studied. It was performed a cross-sectional analysis of a large Mexican population with the infection (n= 681 890). Prevalence of immunosuppression and hypertension was 1.10% and 19.50%, respectively. The adjusted model evidenced that hypertension was significantly associated with immunosuppression (odds ratio=1.18, 95% CI=1.11-1.25). Further research in pathways that justify the association between hypertension and immunosuppression in COVID-19 patients is recommended.

Original languageEnglish
Article numberem297
JournalElectronic Journal of General Medicine
Volume18
Issue number4
DOIs
StatePublished - 2021

Keywords

  • COVID-19
  • Hypertension
  • Mexico
  • Public health
  • Severe acute respiratory syndrome coronavirus 2

Fingerprint

Dive into the research topics of 'Association between hypertension and immunosuppression in sars-cov-2 infection'. Together they form a unique fingerprint.

Cite this